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Introduction: Human milk is the optimal nutrition for preterm infants. When the mother’s
own milk is unavailable, donor human milk is recommended as an alternative for preterm
infants. The association among early nutrition, body composition and the future risk of
disease has recently attracted much interest. The aim of this study was to investigate the
effect of human milk on the body composition of preterm infants.
Materials and Methods: Very low birth weight infants (VLBW: birth weight <1,500 g)
with a gestational age (GA) between 26 and 34 weeks were included. Clinical data,
anthropometric measurements and nutritional intake in terms of the volume of human
milk were extracted from computerized medical charts. The human milk intake was
expressed as a percentage of target fortified donor human milk and/or target fortified
freshmother’s milk, compared with the total volume of milk intake during the hospital stay.
All included infants underwent anthropometric measurements and body composition
analysis (expressed as fat-free mass percentage) at term corrected age (CA) by
air-displacement plethysmography. A comparison between infants fed human milk at
<50% (group 1) and infants fed human milk at ≥50% of the total volume of milk intake
(group 2) was conducted. Multiple linear regression analyses were conducted to explore
the modulating effect of fortified human milk on fat-free mass at term CA.
Results: Seventy-three VLBW infants were included in the study. The mean weight and
GA at birth were 1,248 ± 198 g and 30.2 ± 2.0 weeks, respectively. No differences were
found regarding anthropometric measurements at birth, at discharge and at term CA
between the two groups. The mean fortified human milk intake was 34.9 ± 12.5 and
80.9 ± 15.5% in groups 1 and 2, respectively (p < 0.001).
Amultiple regression analysis corrected for sex and birth weight demonstrated that intake
of ≥50% fortified human milk was associated with a higher fat-free mass percentage at
term CA than intake of <50% fortified human milk.
Conclusion: The use of target fortified human milk modulated growth and improved
growth quality in vulnerable preterm infants. Thus, the use of donor human milk should
be encouraged when fresh mother’s milk is insufficient or not available.
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INTRODUCTION
Human milk is the optimal nutrition for preterm infants.
Increasing evidence has demonstrated that mother’s own milk
provides significant benefits for extremely preterm infants, such
as the prevention of infection and necrotizing enterocolitis and a
reduction in the duration of hospital stay (1). In addition, it has
been reported that these benefits are modulated according to the
dose of human milk fed during hospitalization (2, 3).
Mother’s own milk is at the top of the biological hierarchy;
therefore, it is always preferable to other sources of milk (4).
Nevertheless, donor human milk can be a bridge until a mother’s
ownmilk is available and sufficient tomeet her infant’s nutritional
needs (1, 5). Indeed, in a recent meta-analysis, mother’s own
milk supplemented with donor humanmilk was associated with a
reduced risk in the development of bronchopulmonary dysplasia
in very preterm infants compared with that supplemented
with preterm formula (6). In 2014, Quigley and McGuire
demonstrated that formula-fed preterm and low birth weight
infants had higher rates of short-term growth but also a higher
risk of developing necrotizing enterocolitis than those who were
fed donor human milk (7).
The association among early nutrition, growth, growth
quality, and the future risk of developing noncommunicable
diseases has attracted much interest in recent years.
In a recent study on the growth of late preterm infants,
we demonstrated that being fed human milk is associated with
increased fat-free mass deposition at term corrected age (CA) (8).
It has also been reported that formula-fed very preterm infants
show an altered body composition. Specifically, compared with
breastfed very preterm infants, formula-fed very preterm infants
showed increased fat mass at term CA (9, 10), which decreased
toward 6 months CA (11).
Conversely, preterm infants fed fortified mother’s own milk
showed a higher percentage of fat-free mass than formula-fed
infants at term CA (12).
Data regarding the effect of human milk (both fresh mother’s
milk and/or donor human milk) on the modulation of body
composition in preterm infants are scarce. Therefore, the aim of
this study was to investigate the effect of human milk (both fresh
mother’s milk and/or donor human milk) on growth and body
composition in preterm infants.
MATERIALS AND METHODS
The Ethics Committee of the Fondazione Istituto di Ricovero
e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore
Policlinico approved the study, and written informed consent
was obtained from the parents. All clinical investigations were
conducted according to the principles outlined in the Declaration
of Helsinki.
Study Design
A longitudinal observational study was conducted.
Very low birth weight infants (VLBW: birth weight <1,500 g)
born between May 2016 and December 2017 at the authors’
institution with gestational age (GA) at birth from 26+0 to 33+6
weeks were included in the study.
The exclusion criteria for all infants screened included the
presence of congenital diseases, chromosomal abnormalities
or cardiac, brain, renal, endocrine or surgical diseases, which
can interfere with growth. In addition, infants who required
ventilatory assistance and intravenous nutritional support at term
CA were excluded.
GA was based on the last menstrual period and first trimester
ultrasonogram. CA was calculated using the chronological age
and adjusted for GA, which is the number of additional weeks
from term (40 weeks) (13).
Data Collection and Nutritional Practices
Clinical data, anthropometric measurements, and nutritional
intake in terms of the volume of human milk intake (both fresh
mother’s milk and/or donor humanmilk) during the hospital stay
were acquired from computerized medical charts (Neocare R©).
Parenteral nutrition was started on the first day of life. The
parenteral solutions were prepared by the hospital pharmacy
according to the medical prescription. The provided volume
increased from 80 to 90 ml/kg on the first day to 150–180 ml/kg
on the 7th day of life, with an energy/protein ratio from 20.8–24
kcal/g on the first day up to 23.1–27.7 kcal/g on the 7th day of life.
Weaning from parenteral nutrition was scheduled to obtain
a weight velocity >15 g/kg/day. To achieve this goal, the
macronutrients were reduced gradually according to weight
velocity. Table 1 shows the parenteral nutrition practices
according to the internal procedure.
Enteral feeding was started within 24 h of postnatal life using
fresh mother’s milk. When fresh mother’s milk was unavailable
or insufficient, donor human milk was started following the
acquisition of written informed consent from the parents. In case
of lack of parents’ consent, infants were fed with preterm formula
(energy: 83 kcal/100ml; carbohydrates: 8.4 g/100ml; proteins: 2.7
g/100ml; fat: 4.1 g/100ml).
For infants with birth weights less than 1,000 g and/or with
severe intrauterine growth restriction (<3th percentile according
to INTERGROWTH-21st reference curves) (14), enteral feeding
was started at 10 ml/kg/day and remained stable for the first 3
days of life. On the fourth day of life, an increase of 10 ml/kg/day
was scheduled.
For infants with birth weights greater than or equal to
1,000 g without severe intrauterine growth restriction (<3th
percentile according to INTERGROWTH-21st reference curves)
(14), enteral feeding was started at 20 ml/kg/day and remained
stable for the first 2 days of life. After the third day of life, an
increase of 20 ml/kg/day was scheduled.
Enteral nutrition was stopped in cases of septic shock, needs
for exsanguinotrasfusion, abdominal distension with a visible
intestinal loop, and gastric residual volumes >2 ml/kg for infants
with birth weights <750 g, >3 ml/kg for infants with birth
weights ranging from 751 to 1,000 g and >5 ml/kg for infants
with birth weights greater than 1,000 g.
When the infants tolerated an enteral intake ≥80 ml/kg, a
target human milk fortification was started.
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TABLE 1 | Parenteral nutrition practices.
Day of life 1 2 3 4 5 6 ≥7
Birth weight (g) <1000g >1000g <1000g >1000g <1000g >1000g <1000g >1000g <1000g >1000g <1000g >1000g <1000g >1000g
Volume (ml/kg) 80–90 80 90–100 90 110–120 100–110 120–140 110–120 140–160 120–130 150–160 140–150 150–160 150–160
Glucose (g/kg) 8 9 8 9 9 10–11 9 10–13 10 10–14 10–13 10–14 10–14 10–14
Lipids (g/kg) 2–2.5 2.5 2.5 2.5 2.5 2.5 3 3 3 3 3 3 3 3
Proteins (g/kg) 2.5–3 3 3.5 3 3–3.5 3.5 3–3.5 3,5 3.5–4 3,5 4 3,5 4 3,5
Sodium (mEq/kg) 0 0 0 0 0 0 3 3 3 3 3,5 3.5 4 3.5–4
Potassium (mEq/kg) 0 0 0 0 0 0 2 2 2 2 2 2 3 2–4
Cloride (mEq/kg) 0 0 0 0 0 0 3 3 3 3 3.5 3.5 3.5-6 3.5–4
Calcium (mg/kg) 0 0 60 60 60 70 70 80 80 80 80 80 80 90
Phosphate (mg/kg) 0 0 30 30 30 40 40 50 50 55 55 60 60 70
Magnesium (mEq/kg) 0 0 0.5 0.5 0.5 1 0.5 1 0,5 1 0,5 1 0,5 1
Parenteral nutrition recommendation according to internal procedure (fluids, macronutrients and micronutrients).
Specifically, both donor pasteurized human milk and fresh
mother’s milk were analyzed using a mid-ray spectrometry
human milk analyzer (Miris AB R©).
Pooled donor human milk was created by mixing mature
thawed human milk from 1 to 5 donors enrolled at the Human
Milk Bank at the authors’ institution. Analyses of fresh mother’s
milk were conducted two times/week using a 10-ml sample from
a 24 h fresh milk pool. Analyses of donor human milk were
conducted using a 10-ml sample from each pool after Holder
pasteurization (62.5◦C for 30min) to account for macronutrient
depletion due to storage and pasteurization (15). According
to these results, the medical team prescribed individualized
fortification to comply with the ESPGHAN nutrient intake
guidelines (16).
Human milk fortification was performed using bovine human
milk fortifiers: FM85 (Nestlè) or Aptamil BMF (Nutricia)
as polymeric fortifiers, Aptamil PS (Nutricia) for protein
supplementation, and medium-chain triglyceride (MCT) oil
(Medifood) for energy provision.
Human milk intake was expressed as the volume of fortified
donor human milk and/or fortified fresh mother’s milk.
The percentage of human milk intake was computed from the
volume of human milk intake compared with the total volume
of milk intake during the hospital stay (fortified donor human
milk+fortified fresh mother’s milk+formula milk). In addition,
the proportion of mothers’ own milk within the total volume of
humanmilk intake was computed (fresh mother’s milk intake %).
Anthropometric Measurements
Body weight, body length and head circumference of all infants
included in the study were assessed at birth and at term CA
according to standard procedures (17, 18). In detail, a subject’s
body weight was measured on an electronic scale accurate to
the nearest 0.1 g (PEA POD Infant Body Composition System;
COSMED, Italy), body length was measured to the nearest mm
using a recumbent infant length board, and head circumference
was measured to the nearest 1mm using a nonstretch measuring
tape.
Infants with birth weights below the 10th percentile according
to INTERGROWTH-21st reference curves (14) were categorized
as small for gestational age (SGA).
The weight z-scores at birth and at discharge were calculated
according to INTERGROWTH-21st reference and standard
curves, respectively (14, 18).
The daily growth rate was calculated using the exponential
regression model described by Patel et al. (19) as follows:
[1000×ln(W2/W1)]/(D2− D1) (1)
where W= weight in grams; D= day; 1= beginning of the time
interval; and 2=end of the time interval (19).
Body Composition Assessment
Body composition was assessed at term CA for all infants
included in the study using an air-displacement plethysmography
system (PEA POD Infant Body Composition System; COSMED,
Italy) (20, 21). The PEA POD assesses FM and FFM by bodymass
and body volume measurements via the application of whole-
body densitometric principles. Body density was computed
from the study subject’s measured mass and volume and then
converted to indicate the total absolute (g) and percentage
(%) of FM and FFM using sex-specific equations developed
by Fomon et al. (22). The observers were health professionals
trained to perform anthropometric and body composition
measurements according to our standard procedure. The
interobserver coefficient of variation for the FM percentage
estimates was 0.3%.
Statistical Analysis
Continuous variables are reported as the mean and standard
deviation (SD). Categorical variables are reported as absolute
numbers or percentages. Comparisons between infants fed
human milk (fresh mother’s milk or donor human milk) at less
than 50% of the total volume of milk intake during the hospital
stay (group 1) and infants fed human milk at greater or equal to
50% of the total volume of milk intake during the hospital stay
(group 2) were conducted using the X2 test for discrete variables
and analysis of variance for continuous variables.
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TABLE 2 | Basic characteristics at birth of infants included.
All infants
(n = 73)
Group 1
(n = 24)
Group 2
(n = 49)
p
Weight (g) 1248 ± 198 1207 ± 208 1269 ± 193 0.215
Length (cm) 38.3 ± 2.8 37.7 ± 3.3 38.6 ± 2.6 0.278
Head Circumference (cm) 26.8 ± 1.9 26.5 ± 2.3 27.0 ± 1.7 0.358
Gestational age (weeks) 30.2 ± 2.0 30.0 ± 2.4 30.3 ± 1.8 0.632
Males: n (%) 32 (43.9) 10 (41.6) 22 (44.9) 0.797
Twins: n (%) 35 (48.5) 13 (54.1) 22 (44.9) 0.463
SGA infants n (%) 25 (34.2) 9 (37.5) 14 (28.6) 0.305
Antenatal steroids n (%) 70 (95.9) 23 (95.8) 47 (95.9) 0.704
Need of invasive ventilatory
assistance n (%)
17 (23.3) 5 (20.8) 12 (24.5) 0.558
Duration of invasive
ventilatory assistance (days)
0.88 ± 2.0 0.61 ± 1.7 1.0 ± 2.1 0.446
Need of non-invasive
ventilatory assistance n (%)
41 (56.1) 15 (62.5) 26 (53.1) 0.558
Duration of invasive
ventilatory assistance (days)
20.94 ± 21.0 19.74 ± 23.7 21.53 ± 19.8 0.741
Data are expressed as mean ± standard deviation or n (%). The duration of ventilatory
assistance were expressed as days of treatment.
Multiple linear regression analyses were conducted to explore
the role of fortified human milk in modulating fat-free mass at
term CA according to sex and birth weight. Indeed, it has been
reported that gender can influence body composition at term
CA (23).
Statistical significance was set at a level of 0.05. All statistical
analyses were performed using SPSS software (SPSS, version 20;
SPSS, Chicago, IL).
RESULTS
Seventy-three VLBW infants were included in the study. The
basic characteristics at birth are shown in Table 2. No differences
were detectable at birth between the two study groups.
The infants included in the study received parenteral nutrition
for 21.9 ± 9.0 days, and full enteral feeding was achieved at 28.9
± 9.0 days of life; no differences were found between the two
groups.
Data regarding human milk intake (fresh mother’s milk
and/or pasteurized donor human milk) are shown in Table 3.
The mean energy and protein intake were 65.7 ± 16.4
Kcal/kg/day and 2.9 g/kg/day during the first week of life, 124.8
± 13.8 kcal/kg/day and 3.3 ± 0.7 g/kg/day when full enteral
feeding was achieved, and 130.8 ± 14.2 kcal/kg/day and 3.6 ±
0.6 g/kg/day at discharge, respectively. No differences in energy
and protein intake between the two study groups were detectable
during the hospital stay.
The weight z-score at birth and at discharge and the daily
growth rates are shown in Table 4.
No differences were found in weight z-score at birth or at
discharge between the two groups. Group 1 had a higher growth
rate than group 2 both after reaching full enteral feeding (milk
TABLE 3 | Milk volume intake during hospital stay.
All infants
(n = 73)
Group 1
(n = 24)
Group 2
(n = 49)
p
Total Milk volume
intake (ml)
10357.1 ± 5871.7 11713.1 ± 7756.7 9692.9 ± 4638.5 0.169
Human milk daily
intake (ml/day)
118.2 ± 47.3 65.6 ± 25.9 144.0 ± 31.2 <0.001
Human milk volume
intake (ml)
6385.4 ± 3498.9 3998.6 ± 2590.8 7554.4 ± 3302.1 <0.001
Human milk volume
intake (%)
65.8 ± 26.1 34.9 ± 12.5 80.9 ± 15.5 <0.001
Fresh mother milk
intake (%)
64.7 ± 42.6 41.9 ± 43.7 75.9 ± 37.6 0.001
Data are expressed as mean ± standard deviation. The percentage of human milk intake
was computed from the volume of human milk intake compared with the total volume of
milk intake during the hospital stay (fortified donor human milk + fortified fresh mother’s
milk+formula milk). Fresh mother milk intake (%) is the proportion of mothers’ own milk
within the total volume of human milk.
TABLE 4 | Weight z-score and daily growth rate during hospital stay.
All infants
(n = 73)
Group 1
(n = 24)
Group 2
(n = 49)
p
Birth weight z-score −0.60 ± 0.97 −0.61 ± 1.2 −0.59 ± 0.84 0.941
Weight at discharge z-score −1.26 ± 1.01 −1.14 ± 1.27 −1.32 ± 0.87 0.504
Daily growth rate during
parenteral nutrition (g/kg/day)
20.23 ± 5.38 21.99 ± 4.35 19.4 ± 5.67 0.051
Daily growth rate during full
enteral feeding (g/kg/day)
15.32 ± 8.06 18.65 ± 12.24 13.70 ± 4.17 0.013
Total daily growth rate during
hospital stay (g/kg/day)
16.07 ± 2.42 17.30 ± 2.74 15.46 ± 2.01 0.002
Data are expressed as mean± standard deviation. The daily growth rates were calculated
during the administration of parenteral nutrition, after reaching full enteral feeding (milk
volume intake ≥150 ml/kg/day) and during all the hospital stay.
volume intake≥150 ml/kg/day) and during the entire hospital
stay.
The incidence of comorbidities developed during
hospitalization was similar in group 1 and group 2. Among
all infants included in the study, none developed NEC, 9.6%
had cholestasis, 5.5% had bronchopulmonary dysplasia, 9.6%
received treatment for patent ductus arteriosus, and 17.8% had
sepsis.
The characteristics at discharge and at term CA according to
the mode of feeding are shown inTables 5, 6. No differences were
found between the two groups regarding the anthropometric
measurements and body composition at discharge or at term CA.
The infants included in the study achieved the ability to feed
orally beginning at 36.4 ± 1.4 weeks of postmenstrual age. No
differences were found between groups.
Multiple logistic regression analysis showed that there was
a positive association between the human milk volume intake
percentage and fat-free mass percentage after correction for birth
weight and gender (β = 0.12 ± 0.05, p = 0.01). Specifically,
the regression model showed that being fed with human milk at
more than or equal to 50% of total milk intake was associated
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TABLE 5 | Characteristics at discharge according to mode of feeding.
All infants
(n = 73)
Group 1
(n = 24)
Group 2
(n = 49)
p
Weight (g) 2404 ± 424 2471 ± 514 2371 ± 373 0.349
Length (cm) 45.1 ± 2.2 45.3 ± 2.2 44.9 ± 2.2 0.544
Head Circumference (cm) 32.0 ± 2.0 32.2 ± 1.7 31.9 ± 2.1 0.604
Postmenstrual age (weeks) 37.7 ± 1.5 37.8 ± 1.4 37.6 ± 1.6 0.470
Length of stay (days) 51.9 ± 18.5 52.8 ± 19.4 51.4 ± 18.1 0.763
Data are expressed as mean ± standard deviation.
TABLE 6 | Anthropometric measurements and body composition at term
corrected age according to mode of feeding.
All infants
(n = 73)
Group 1
(n = 24)
Group 2
(n = 49)
p
Weight (g) 3088 ± 476 3142 ± 628 3062 ± 386 0.506
Length (cm) 48.5 ± 2.3 48.4 ± 2.7 48.6 ± 2.1 0.774
Head Circumference (cm) 34.6 ± 1.3 34.4 ± 1.7 34.7 ± 1.1 0.346
Fat free mass (%) 82.0 ± 11.1 78.6 ± 18.1 83.7 ± 4.5 0.067
Data were expressed ad mean ± standard deviation.
TABLE 7 | Multiple regression analysis model for fat free mass %.
Beta coefficients 95% Interval of
confidence
p
Intercept 95.518 ± 7.876 79.805; 111.231 <0.001
Being male (no vs. yes) 4.396 ± 2.481 −0.552; 9.345 0.081
Birth weight (g) −0.01 ± 0.006 −0.028; −0.003 0.016
Being fed human milk
≥50% (no vs. yes)
5.883 ± 2.638 0.621; 11.146 0.029
Multiple regression analysis model corrected by gender and birth weight. Being fed with
humanmilk more than or equal to 50%was positively associated with a significant increase
in fat free mass percentage at term CA.
with a significant increase in fat-free mass percentage at term CA
(Table 7).
DISCUSSION
This study examined the relationship between the type of
feeding and body composition in VLBW infants. Specifically,
we demonstrated that VLBW infants fed human milk (both
fresh mother’s milk and/or donor human milk) at more than or
equal to 50% of the total milk volume intake during the hospital
stay displayed an increased fat-free mass percentage at term CA
compared to VLBW infants fed human milk at less than 50% of
the total milk intake.
Johnson et al. demonstrated that VLBW infants had a fat-
free mass deficit at term CA compared to full-term infants (24).
Increasing evidence has demonstrated that greater fat-free mass
deposition is associated with an improved neurodevelopmental
outcome (25). A study conducted at our center demonstrated that
human milk feeding is positively associated with fat-free mass
deposition in late preterm infants (8).
Our results showed that infants fed human milk at less than
50% of the total milk intake had a higher growth rate than their
counterparts. On the other hand, the weight and weight z-score at
discharge were similar between the two groups. It must be noted
that most of the infants fed fresh mother’s milk were in group
2, and consequently, the higher number of breastfed infants can
explain the lower growth rate in these infants than in formula-fed
infants. Indeed, after reaching full enteral feeding and, above all,
after reaching the ability to feed orally, breastfed infants cannot
receive adequate fortification from feedings taken directly from
the breast. A similar weight was found at term CA between the
two groups. Indeed, considering the weight increase percentage
between discharge and term CA, infants in group 2 show a
slightly higher value than those in group 1 (+31.4 vs. 28.3%),
probably due to better adaptation of group 2 infants than group
1 infants after discharge.
To the best of our knowledge, this was the first study to explore
the modulating effect of both fresh mother’s milk and donor
humanmilk on body composition. In a previous study conducted
in our center, Morlacchi et al. demonstrated that preterm infants
fed fortified mother’s own milk showed a higher percentage
of fat-free mass than formula-fed infants at term CA, which
was probably due to the higher nitrogen balance in breastfed
infants than in formula-fed infants (12). In our study, we did not
evaluate infant nitrogen balance; however, we can speculate that
being fed both fortified fresh mother’s milk and/or donor human
milk can result in a similar metabolic response to that obtained
by feeding exclusively fresh mother’s milk. In addition, in the
univariate regression analysis, the percentage of fresh mother’s
milk intake was not associated with FFM deposition, whereas the
total human milk volume intake was positively associated with
the FFM percentage at term CA. This observation can most likely
be explained by the relatively low percentage of fresh humanmilk
ingested by infants included in the study.
It has been reported that exclusive breastfeeding is associated
with lower growth rates in preterm infants than formula feeding
(26), especially with standard fortification of human milk (27).
In fact, the mean protein content decreases during lactation,
while the nutrient needs of VLBW infants remain high (28, 29).
In addition, although it has been reported that donor human
milk provides nutrients comparable to mother’s milk, preterm
infants fed donor humanmilk fortified similarly to fresh mother’s
milk according to standard methods showed an increased risk
of postnatal growth restriction (30, 31). In contrast, it has been
reported that fortification of donor human milk to reach 3.5
g/kg of protein intake is associated with significantly greater
weight gain and head growth in VLBW infants than feeding
a formula-based diet (30). In addition, targeted fortification of
human milk seems to represent an optimal strategy to prevent
postnatal growth restriction (32, 33).
According to our internal procedure, when infants tolerated
an enteral intake of human milk (both fresh mother’s milk
and/or donor human milk) ≥80 ml/kg/day, targeted human
milk fortification is initiated to meet the ESPGHAN guidelines.
Consequently, infants fed fortified human milk at more than or
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equal to 50% of the total milk volume intake during the hospital
stay exhibited similar growth at discharge as infants fed less
human milk.
In a recent study of 34 VLBW infants (11 breastfed and
23 formula-fed) compared with a control group of 19 full-
term infants, it was demonstrated that formula-fed infants were
heavier than breastfed infants at term CA and showed higher
amounts of adipose tissue and lower amounts of fat-free mass
than full-term infants. However, breastfed preterm infants had
a similar body composition as full-term infants (34, 35).
In our study, we did not observe any difference in body weight
between the two groups, irrespective of the type of feeding, both
at discharge and at term CA. Nevertheless, infants in group 2
who were fed ∼81% human milk during their hospital stay had
an increased fat-free mass at term CA compared with infants
in group 1 who were fed only 35% human milk from birth to
discharge.
It has been taken into account that in our study, the donor
human milk constituted 58% and 25% of the total amount of
human milk intake in group 1 and group 2, respectively. This
detail underlines the important effect of fresh mother’s milk on
growth and quality of growth but suggests that donor human
milk is preferred over formula milk when fresh mother’s milk is
not available or is insufficient to satisfy the infant’s nutritional
needs. Therefore, the strength of the study was the use of
donor human milk to supplement fresh mother’s milk and the
practice of targeted fortification to achieve the nutritional needs
of preterm infants.
It must also be taken into account that the infants included
in this study were all clinically stable at term CA during the
assessment of body composition, and therefore, the results
obtained in this study cannot be applied to sick infants. In
addition, a limitation of the study is that it is not a randomized
controlled trial, although this type of study design has ethical
issues.
In conclusion, the use of target fortified human milk
modulated the growth of and improved the quality of growth
in vulnerable preterm infants. The use of fortified donor human
milk when fresh mother’s milk is insufficient or not available
should be encouraged.
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